Literature DB >> 15897506

Giant axonal neuropathy: clinical and genetic study in six cases.

E Demir1, P Bomont, S Erdem, L Cavalier, M Demirci, G Kose, S Muftuoglu, A N Cakar, E Tan, S Aysun, M Topcu, P Guicheney, M Koenig, H Topaloglu.   

Abstract

BACKGROUND: Giant axonal neuropathy (GAN) is a severe recessive disorder characterised by variable combination of progressive sensory motor neuropathy, central nervous system (CNS) involvement, and "frizzly" hair. The disease is caused by GAN gene mutations on chromosome 16q24.1. AIMS: To search for GAN gene mutations in Turkish patients with GAN and characterise the phenotype associated with them.
METHODS: Linkage and mutation analyses were performed in six affected patients from three consanguineous families. These patients were also investigated by cranial magnetic resonance imaging (MRI) and electroencephalography (EEG). Electromyography (EMG) was performed in heterozygous carriers from family 1 and family 3.
RESULTS: Linkage to 16q24.1 was confirmed by haplotype analysis. GAN mutations were identified in all families. Family 1 had the R293X mutation, previously reported in another Turkish family. Families 2 and 3, originating from close geographical areas, shared a novel mutation, 1502+1G>T, at the donor splice site of exon 9. All patients displayed a common phenotype, including peripheral neuropathy, cerebellar ataxia, and frizzly hair. Cranial MRI showed diffuse white matter abnormalities in two patients from family 1 and the patient from family 3, and minimal white matter involvement in the patient from family 2. EMG of a heterozygous R293X mutation carrier showed signs of mild axonal neuropathy, whereas a 1502+1G>T mutation carrier had normal EMG. EEG abnormalities were found in three patients.
CONCLUSION: These findings highlight the association of CNS involvement, in particular white matter abnormalities, with peripheral neuropathy in GAN. The phenotypical consequences of both mutations (when homozygous) were similar.

Entities:  

Mesh:

Year:  2005        PMID: 15897506      PMCID: PMC1739689          DOI: 10.1136/jnnp.2003.035162

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  39 in total

1.  Giant axonal neuropathy: progressive clinical and radiologic CNS involvement.

Authors:  P Richen; R Tandan
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

2.  Giant axonal neuropathy in 2 siblings: a generalized disorder of intermediate filaments.

Authors:  G C Guazzi; A Malandrini; R Gerli; A Federico
Journal:  Eur Neurol       Date:  1991       Impact factor: 1.710

3.  Giant axonal neuropathy: report on a case with focal fiber loss.

Authors:  M Sabatelli; E Bertini; S Servidei; E Fernandez; S Magi; P Tonali
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Localization of the giant axonal neuropathy gene to chromosome 16q24.

Authors:  K M Flanigan; T O Crawford; J W Griffin; H H Goebel; A Kohlschütter; J Ranells; P R Camfield; L J Ptácek
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

5.  Giant axonal neuropathy with inherited multisystem degeneration in a Tunisian kindred.

Authors:  M Ben Hamida; F Hentati; C Ben Hamida
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

6.  Cavum septi pellucidi and cavum vergae in normal and developmentally delayed populations.

Authors:  J B Bodensteiner; G B Schaefer; J M Craft
Journal:  J Child Neurol       Date:  1998-03       Impact factor: 1.987

7.  Drosophila kelch is an oligomeric ring canal actin organizer.

Authors:  D N Robinson; L Cooley
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

8.  Giant axonal neuropathy with predominant central nervous system manifestations.

Authors:  Y Lampl; Y Eshel; E Ben-David; R Gilad; I Sarova-Pinhas; U Sandbank
Journal:  Dev Med Child Neurol       Date:  1992-02       Impact factor: 5.449

9.  Giant axonal neuropathy: a generalized disorder of intermediate filaments with longitudinal grooves in the hair.

Authors:  S Treiber-Held; H Budjarjo-Welim; D Reimann; J Richter; H A Kretzschmar; F Hanefeld
Journal:  Neuropediatrics       Date:  1994-04       Impact factor: 1.947

10.  ENC-1: a novel mammalian kelch-related gene specifically expressed in the nervous system encodes an actin-binding protein.

Authors:  M C Hernandez; P J Andres-Barquin; S Martinez; A Bulfone; J L Rubenstein; M A Israel
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

View more
  14 in total

1.  3T MR with diffusion tensor imaging and single-voxel spectroscopy in giant axonal neuropathy.

Authors:  Christiana Brenner; Carlos Eduardo Speck-Martins; Luciano Farage; Peter B Barker
Journal:  J Magn Reson Imaging       Date:  2008-07       Impact factor: 4.813

2.  Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease.

Authors:  Diane Armao; Rachel M Bailey; Thomas W Bouldin; Yongbaek Kim; Steven J Gray
Journal:  Clin Auton Res       Date:  2016-07-01       Impact factor: 4.435

3.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

Review 4.  A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.

Authors:  James J Kang; Isabelle Y Liu; Marilene B Wang; Eri S Srivatsan
Journal:  Hum Genet       Date:  2016-03-29       Impact factor: 4.132

5.  Sonic Hedgehog repression underlies gigaxonin mutation-induced motor deficits in giant axonal neuropathy.

Authors:  Yoan Arribat; Karolina S Mysiak; Léa Lescouzères; Alexia Boizot; Maxime Ruiz; Mireille Rossel; Pascale Bomont
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

6.  Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion.

Authors:  Andoni Echaniz-Laguna; Jean-Marie Cuisset; Lucie Guyant-Marechal; Patrick Aubourg; Laurent Kremer; Naziha Baaloul; Alain Verloes; Kouider Beladgham; Jimmy Perrot; Bruno Francou; Philippe Latour
Journal:  Neurogenetics       Date:  2019-10-26       Impact factor: 2.660

7.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

8.  Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

Authors:  Thibault Ganay; Alexia Boizot; Renaud Burrer; Jean Paul Chauvin; Pascale Bomont
Journal:  Mol Neurodegener       Date:  2011-04-12       Impact factor: 14.195

9.  The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test.

Authors:  Alexia Boizot; Yasmina Talmat-Amar; Deborah Morrogh; Nancy L Kuntz; Cecile Halbert; Brigitte Chabrol; Henry Houlden; Tanya Stojkovic; Brenda A Schulman; Bernd Rautenstrauss; Pascale Bomont
Journal:  Acta Neuropathol Commun       Date:  2014-04-24       Impact factor: 7.801

10.  New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy.

Authors:  Henry Houlden; Mike Groves; Zosia Miedzybrodzka; Helen Roper; Tracey Willis; John Winer; Gaynor Cole; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-19       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.